Health Aff (Millwood). 2007 Mar-Apr;26(2):483-91.

Confidentiality laws and secrecy in medical research: improving public access to data on drug safety.

Source

Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts, USA. akesselheim@partners.org

Abstract

Pharmaceutical manufacturers have long considered results collected from drugs' clinical trials to be confidential information or trade secrets, even after submission to the Food and Drug Administration (FDA). We describe FDA policies regarding disclosure of clinical trial data and evaluate how courts have interpreted the Freedom of Information Act in cases seeking access to unreleased information. Recent examples of approved drugs later found to have dangerous side effects show the importance of complete dissemination of safety information. We suggest regulatory and legislative policy changes regarding how the FDA handles confidential information that can improve understanding of the risks of prescription drugs.

PMID:: 17339677; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Grant Support

Publication Types

MeSH Terms

Grant Support

6T32HP1101/PHS HHS/United States

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment. [Food Drug Law J. 2009]
FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
Roller ST, Pippins RR, Ngai JW. Food Drug Law J. 2009; 64(3):577-98.
Review The Internet and drug safety: what are the implications for pharmacovigilance? [Drug Saf. 1999]
Review The Internet and drug safety: what are the implications for pharmacovigilance?
Cobert B, Silvey J. Drug Saf. 1999 Feb; 20(2):95-107.
Review Manufacturer's drug interaction and postmarketing adverse event data: what are appropriate uses? [Drug Saf. 2001]
Review Manufacturer's drug interaction and postmarketing adverse event data: what are appropriate uses?
Kraft WK, Waldman SA. Drug Saf. 2001; 24(9):637-43.
FDA censoring of manufacturers' postmarketing commitments in HIV/AIDS drug approval letters. [Am J Ther. 2000]
FDA censoring of manufacturers' postmarketing commitments in HIV/AIDS drug approval letters.
Unalp A, Shafer C, Tonascia S, Meinert C. Am J Ther. 2000 Aug; 7(4):257-63.
Financial disclosure by clinical investigators--FDA. Final rule; action on petition for reconsideration. [Fed Regist. 1998]
Financial disclosure by clinical investigators--FDA. Final rule; action on petition for reconsideration.
. Fed Regist. 1998 Dec 31; 63(251):72171-81.

See reviews... See all...

Cited by 2 PubMed Central articles

The imperative to share clinical study reports: recommendations from the Tamiflu experience. [PLoS Med. 2012]
The imperative to share clinical study reports: recommendations from the Tamiflu experience.
Doshi P, Jefferson T, Del Mar C. PLoS Med. 2012 Apr; 9(4):e1001201. Epub 2012 Apr 10.
Review Reporting bias in medical research - a narrative review. [Trials. 2010]
Review Reporting bias in medical research - a narrative review.
McGauran N, Wieseler B, Kreis J, Schüler YB, Kölsch H, Kaiser T. Trials. 2010 Apr 13; 11:37. Epub 2010 Apr 13.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Confidentiality laws and secrecy in medical research: improving public access to...
Confidentiality laws and secrecy in medical research: improving public access to data on drug safety.
Health Aff (Millwood). 2007 Mar-Apr ;26(2):483-91.

PubMed
IFI16 in human prostate cancer.
IFI16 in human prostate cancer.
Mol Cancer Res. 2007 Mar ;5(3):251-9. Epub 2007 Mar 5 .

PubMed
Tetrabenazine as antichorea therapy in Huntington disease: a randomized controll...
Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.
Neurology. 2007 Mar 6 ;68(10):797; author reply 797.

PubMed
Serum cholesterol changes after midlife and late-life cognition: twenty-one-year...
Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study.
Neurology. 2007 Mar 6 ;68(10):751-6.

PubMed
Echocardiography in Chagas heart disease.
Echocardiography in Chagas heart disease.
Circulation. 2007 Mar 6 ;115(9):1124-31.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: